OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma
Akash Kaushik, Amy Tarangelo, Lindsey K. Boroughs, et al.
Science Advances (2022) Vol. 8, Iss. 50
Open Access | Times Cited: 38
Akash Kaushik, Amy Tarangelo, Lindsey K. Boroughs, et al.
Science Advances (2022) Vol. 8, Iss. 50
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
The impact of broad glutamine metabolism inhibition on the tumor microenvironment
Tianhe Li, Yun-Ta Chuang, Tian‐Li Wang
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 100984-100984
Open Access | Times Cited: 2
Tianhe Li, Yun-Ta Chuang, Tian‐Li Wang
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 100984-100984
Open Access | Times Cited: 2
DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism
Ray Pillai, Thales Papagiannakopoulous
Cancer Research (2023) Vol. 84, Iss. 3, pp. 349-350
Closed Access | Times Cited: 2
Ray Pillai, Thales Papagiannakopoulous
Cancer Research (2023) Vol. 84, Iss. 3, pp. 349-350
Closed Access | Times Cited: 2
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
(2024)
Open Access
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
(2024)
Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
(2024)
Open Access
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
(2024)
Open Access
HIF2α-dependent inhibition of mitochondrial clustering of glutaminase suppresses clear cell renal cell carcinoma
Boa Kim, Wencao Zhao, Nathan J. Coffey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Boa Kim, Wencao Zhao, Nathan J. Coffey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort
Zedan Zhang, Yi Wang, Wuping Yang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110357-110357
Open Access
Zedan Zhang, Yi Wang, Wuping Yang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110357-110357
Open Access
Biosynthesis-Encoded Lipogenic Acetyl-CoA Measurement Using NMR Reveals Glucose-Driven Lipogenesis and Glutamine’s Alternative Roles in Kidney Cancer
Sihyang Jo, Youngbeom Seo, Thi Ha Nguyen, et al.
Journal of the American Chemical Society (2024)
Closed Access
Sihyang Jo, Youngbeom Seo, Thi Ha Nguyen, et al.
Journal of the American Chemical Society (2024)
Closed Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
eLife (2024) Vol. 13
Open Access
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
eLife (2024) Vol. 13
Open Access
Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma
Christian Frezza, Cissy Yong, Christina Schmidt, et al.
Research Square (Research Square) (2024)
Open Access
Christian Frezza, Cissy Yong, Christina Schmidt, et al.
Research Square (Research Square) (2024)
Open Access
Targeting glutamine use in RCC
Monica Wang
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 151-151
Closed Access | Times Cited: 1
Monica Wang
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 151-151
Closed Access | Times Cited: 1
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma
David A. Braun, Abhishek A. Chakraborty
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 5, pp. 827-840
Open Access | Times Cited: 1
David A. Braun, Abhishek A. Chakraborty
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 5, pp. 827-840
Open Access | Times Cited: 1
Novel Targeted Therapies for Renal Cell Carcinoma
Renée Maria Saliby, Eddy Saad, Chris Labaki, et al.
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 5, pp. 1015-1026
Closed Access | Times Cited: 1
Renée Maria Saliby, Eddy Saad, Chris Labaki, et al.
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 5, pp. 1015-1026
Closed Access | Times Cited: 1
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor
Kathryn M. Lemberg, Eunüs S. Ali, Marcela Krečmerová, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1390-1403
Open Access | Times Cited: 1
Kathryn M. Lemberg, Eunüs S. Ali, Marcela Krečmerová, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1390-1403
Open Access | Times Cited: 1
Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia
Alessia Roma, Lawrence Goodridge, Paul A. Spagnuolo
Oncotarget (2023) Vol. 14, Iss. 1, pp. 947-948
Open Access
Alessia Roma, Lawrence Goodridge, Paul A. Spagnuolo
Oncotarget (2023) Vol. 14, Iss. 1, pp. 947-948
Open Access
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Keene L. Abbott, Ahmed Ali, Bradley I. Reinfeld, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
